Rock Springs Capital is a hedge fund created by Kris Henner to invest in healthcare and biotechnology stocks.
650 S Exeter Street
Maryland, United States
|2018-04-26||Innovent Biologics||Series E||$150M||Ally Bridge Group, Capital Group Private Markets, Cormorant Asset Management, Hillhouse Capital Management, Legend Capital, Lilly Asia Ventures, Taikang Life Insurance Company, and Temasek Holdings|
|2017-12-18||Aptinyx||Series B||$70M||Adage Capital Management, Adams Street Partners, Agent Capital, Bain Capital, Beecken Petty O'Keefe & Company, Frazier Healthcare, Goudy Park Capital, HBM Healthcare Investments, Longitude Capital, LVP, Nan Fung, New Leaf Venture Partners, Northwestern University, Osage University Partners, Partner Fund Management, and PathoCapital|
|2017-12-13||Allakos||Series B||$100M||3x5 Special Opportunity Partners, Alta Partners, LifeSci Advisors, New Enterprise Associates, Partner Fund Management, Redmile Group, RiverVest Venture Partners, Roche Venture Fund, and Samsara BioCapital|
|2017-11-30||resTORbio||Series B||$40M||Fidelity Investments, Nest.Bio Ventures, OrbiMed Advisors, and Quan Capital|
|2017-08-01||Homology Medicines||Series B||$83.5M||5AM Ventures, Alexandria Venture Investments, ARCH Venture Partners, Deerfield Management, Fidelity Investments, HBM Healthcare Investments, Maverick Ventures, Novartis, Osage University Partners, Temasek Holdings, Vida Ventures, and Vivo Capital|